Company: CERO
Filing Date: 2025-05-27
Form Type: POS AM
Source: 0001213900-25-047469
Chunk: 247

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-05-27
Form: POS AM
Chunk 247
---
o Therapeutics Holdings, Inc. 2024 Equity Incentive Plan (the “2024 Plan”) and the CERo Therapeutics Holdings, Inc. 2024 Employee Stock Purchase Plan (the “2024 ESPP”). As of December 31, 2023, the 2016 Plan had options outstanding to purchase a total of 7,825 shares of common stock for a weighted average exercise price of $28.00 per share. On February 14, 2024, upon consummation of the Business Combination, these options were assumed by us and converted into options to purchase shares in CERo at a conversion rate of 0.064452 underlying shares per legacy share and a strike price calculated as the legacy strike price divided by 0.064452. This resulted in the issuance of options to purchase 504 shares of common stock at a weighted average price of $436.00. As of October 1, 2024, the board of directors approved option awards to the executive officers for 2024, as set forth below:

| Name and Position                                               |     | Stock   
 Options |        |
| Chris Ehrlich, Chief Executive Officer and Chairman(1)          |     |         | 25,500 |
| Andrew “Al” Kucharchuk, Chief Financial Officer                 |     |         |  5,000 |
| Kristen Pierce, Ph.D., Chief Development Officer                |     |         |  2,659 |
| Brian G. Atwood, Former Chief Executive Officer and Chairman(2) |     |         |  5,080 |
| Charles R. Carter, Former Chief Financial Officer(3)            |     |         |      — |
| Daniel Corey, M.D., Former Chief Technology Officer(4)          |     |         |      — |

| (1) | Excludes 5,272 options granted under the 2024 Plan which 
 were forfeited on September 30, 2024.                    |

| (2) | Excludes 13,318 options granted under the 2024 Plan which 
 were forfeited on September 30, 2024.                     |

| (3) | Excludes 4,954 options granted under the 2024 Plan which 
 were forfeited on September 30, 2024.                    |

| (4) | Excludes 4,613 options granted under the 2024 Plan which 
 were forfeited on September 23, 202